Search results
Testosterone for Women? The Benefits & Risks - Sherri McMillan
The Columbian· 5 days agoTestosterone therapy for women: know the risks and benefits and learn if you are an ideal candidate....
FDA’s Sarepta decision could represent ‘new way of thinking’ for agency - Boston Business Journal
The Business Journals· 8 hours agoThe U.S. Food and Drug Administration’s recent decision to expand approval for a Cambridge company’s controversial gene therapy could signal a changing approach to how the ...
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration allowed the expanded use of Sarepta Therapeutics'...
Taysha Gene Therapies’ (TSHA) “Buy” Rating Reaffirmed at Chardan Capital
ETF DAILY NEWS· 5 days agoChardan Capital reiterated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. Chardan Capital currently ...
Sarepta Duchenne gene therapy wins broader use from FDA
BioPharma Dive via Yahoo Finance· 4 days agoThe approval makes Elevidys available to most Duchenne patients at least 4 years of age, despite...
Gene Therapy for Duchenne Muscular Dystrophy Gets Expanded Approval
MedPage Today· 3 days agoThe FDA expanded the approval of delandistrogene moxeparvovec-rokl (Elevidys) gene therapy for...
Sarepta’s Duchenne gene therapy wins expanded FDA approval - Boston Business Journal
The Business Journals· 3 days agoThe FDA has expanded its previous approval for Sarepta Therapeutics’ gene therapy to treat Duchenne...
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The Conversation· 4 days agoIn the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Car-T therapy, short for “chimeric antigen receptor T-cell ...
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 3 days agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment....
Researchers use diabetes medication as effective drug therapy for sleep-related disorder
Investing.com· 2 days agoLondon, June 22 (IANS) A team of researchers have demonstrated the potential of tirzepatide, known...